Chemed (CHE) to Post Earnings on Tuesday

Chemed (NYSE:CHE) will likely be issuing its Q2 2026 results after the market closes on Tuesday, July 28th. Analysts expect the company to post earnings of $5.60 per share and revenue of $665.0360 million for the quarter. Individuals can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 10:00 AM ET.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The firm had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter last year, the company posted $5.63 EPS. The firm’s quarterly revenue was up 1.6% on a year-over-year basis. On average, analysts expect Chemed to post $23 EPS for the current fiscal year and $26 EPS for the next fiscal year.

Chemed Stock Down 0.2%

Chemed stock opened at $510.28 on Monday. The company has a market capitalization of $6.77 billion, a PE ratio of 27.81, a price-to-earnings-growth ratio of 1.88 and a beta of 0.52. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. Chemed has a fifty-two week low of $365.20 and a fifty-two week high of $517.74. The firm has a 50 day moving average price of $458.59 and a 200 day moving average price of $433.61.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed’s dividend payout ratio (DPR) is currently 13.08%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CHE. Wall Street Zen cut Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Royal Bank Of Canada increased their target price on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research note on Monday, April 27th. Bank of America increased their target price on Chemed from $450.00 to $510.00 and gave the stock a “neutral” rating in a research note on Thursday, July 9th. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Finally, Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $480.25.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the sale, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director directly owned 4,578 shares of the company’s stock, valued at $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 3.33% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Chemed

Institutional investors and hedge funds have recently made changes to their positions in the stock. Alberta Investment Management Corp acquired a new stake in Chemed in the fourth quarter valued at approximately $1,241,000. Mercer Global Advisors Inc. ADV grew its holdings in Chemed by 29.7% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 2,939 shares of the company’s stock worth $1,258,000 after acquiring an additional 673 shares in the last quarter. EP Wealth Advisors LLC acquired a new position in Chemed during the 4th quarter worth approximately $451,000. Strong Retirement Solutions LLC acquired a new position in Chemed during the 4th quarter worth approximately $2,571,000. Finally, Cim LLC increased its position in shares of Chemed by 7.0% in the 4th quarter. Cim LLC now owns 2,288 shares of the company’s stock valued at $979,000 after purchasing an additional 149 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.